Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders

Name: Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders
SKU: 3053
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 36 No. 4 Articles Tags: antidepressant, bipolar-disorder, carlos-a-zarate, depression, felbamate, glutamate, husseini-k-manji, jennifer-payne, jorge-quiroz, medworks-media, memantine, mood-stabilizer, nmdaampakainate, psychopharmacology-bulletin, riluzole

Description

Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders

Description

Carlos A. Zarate, MD

TRANSLATIONAL NEUROSCIENCE

Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders

Carlos A. Zarate, MD, Jorge Quiroz, MD, Jennifer Payne, MD, and Husseini K. Manji, MD

Zonisamide for Bipolar Depression by Deborah Dauphinais

Antipsychotic Induced Symptomatic Hyperprolactinemia

Antipsychotics Case Study by Yuan-Hwa Chou

What Mood Symptoms may be most Difficult to Rate?

Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders

Description

Carlos A. Zarate, MD

TRANSLATIONAL NEUROSCIENCE

Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders

Carlos A. Zarate, MD, Jorge Quiroz, MD, Jennifer Payne, MD, and Husseini K. Manji, MD

Related products

Zonisamide for Bipolar Depression by Deborah Dauphinais

Antipsychotic Induced Symptomatic Hyperprolactinemia

Antipsychotics Case Study by Yuan-Hwa Chou

What Mood Symptoms may be most Difficult to Rate?